Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease.
Elisabetta PatornoPhyo Than HtooBrendan M EverettSeoyoung C KimPublished in: Annals of internal medicine (2022)